Request To Download Free Sample of This Strategic Report @ Highlighted with 43 tables and 86 figures, this 160-page report ?Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five years from now. Berkshire Hathaway is hardly doomed. It's not even expected to ...

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the ...

Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...

Eli Lilly's current market cap is right around ... underscoring the argument for holding some in your portfolio as well. Finally, add Taiwan Semiconductor Manufacturing Company (NYSE: TSM) to ...

Hanmi and Eli Lilly began a development and marketing deal in 2015 for the drug. Lilly received worldwide rights to the molecule for all indications excluding China, Hong Kong, Taiwan, and Korea.

Formerly the Global VP at Labcorp, Patrick led the Central Laboratory Services business unit. His leadership experience spans roles at Eli Lilly, Mossberg Labs, Bayer Healthcare, and Merck & Co.

Central University Hospital announced on the 10th that it has introduced a state-of-the-art linear accelerator that can ...